{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:05:36Z","timestamp":1787875536065,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.intimp.2023.109797","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T20:43:14Z","timestamp":1675370594000},"page":"109797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Decreased frequency of regulatory T cells and level of helios gene expression in secondary progressive multiple sclerosis patients: Evidence about the development of multiple sclerosis"],"prefix":"10.1016","volume":"116","author":[{"given":"Mona","family":"Tarighi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Saadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolreza","family":"Daraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alizadeh khatir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiya","family":"Rahimifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-7425","authenticated-orcid":false,"given":"Mousa","family":"Mohammadnia-Afrouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2023.109797_b0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13760-012-0061-x","article-title":"Self-tolerance in multiple sclerosis","volume":"112","author":"Gonsette","year":"2012","journal-title":"Acta Neurologica Belgica."},{"key":"10.1016\/j.intimp.2023.109797_b0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.intimp.2023.109797_b0015","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review","volume":"6","author":"Waubant","year":"2019","journal-title":"Annals of clinical and translational neurology."},{"issue":"11","key":"10.1016\/j.intimp.2023.109797_b0020","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s40263-020-00771-z","article-title":"Siponimod: a review in secondary progressive multiple sclerosis","volume":"34","author":"Scott","year":"2020","journal-title":"CNS drugs."},{"issue":"6","key":"10.1016\/j.intimp.2023.109797_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2217\/nmt-2019-0024","article-title":"Diagnosis and management of secondary-progressive multiple sclerosis: time for change","volume":"9","author":"Oh","year":"2019","journal-title":"Neurodegenerative disease management."},{"issue":"1","key":"10.1016\/j.intimp.2023.109797_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clinical & Experimental Immunology."},{"issue":"3","key":"10.1016\/j.intimp.2023.109797_b0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.2006.03271.x","article-title":"Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients","volume":"147","author":"Feger","year":"2007","journal-title":"Clinical & Experimental Immunology."},{"issue":"5","key":"10.1016\/j.intimp.2023.109797_b0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nn.4528","article-title":"Regulatory T cells promote myelin regeneration in the central nervous system","volume":"20","author":"Dombrowski","year":"2017","journal-title":"Nature neuroscience."},{"issue":"2","key":"10.1016\/j.intimp.2023.109797_b0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:JOCI.0000019780.93817.82","article-title":"Circulating CD4+ CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs","volume":"24","author":"Putheti","year":"2004","journal-title":"Journal of clinical immunology."},{"issue":"9","key":"10.1016\/j.intimp.2023.109797_b0050","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.4049\/jimmunol.180.9.6411","article-title":"Natural naive CD4+ CD25+ CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression","volume":"180","author":"Venken","year":"2008","journal-title":"The Journal of Immunology."},{"issue":"1","key":"10.1016\/j.intimp.2023.109797_b0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients","volume":"81","author":"Huan","year":"2005","journal-title":"Journal of neuroscience research."},{"issue":"7","key":"10.1016\/j.intimp.2023.109797_b0060","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"The Journal of experimental medicine."},{"issue":"6","key":"10.1016\/j.intimp.2023.109797_b0065","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.1500801","article-title":"Control of regulatory T cell migration, function, and homeostasis","volume":"195","author":"Campbell","year":"2015","journal-title":"The Journal of Immunology."},{"issue":"3","key":"10.1016\/j.intimp.2023.109797_b0070","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4049\/jimmunol.1200792","article-title":"Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells","volume":"190","author":"Baine","year":"2013","journal-title":"The Journal of Immunology."},{"issue":"6","key":"10.1016\/j.intimp.2023.109797_b0075","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.39091","article-title":"Helios enhances Treg cell function in cooperation with FoxP3","volume":"67","author":"Takatori","year":"2015","journal-title":"Arthritis & rheumatology."},{"issue":"2","key":"10.1016\/j.intimp.2023.109797_b0080","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000495","article-title":"The role of the Ikaros family of transcription factors in regulatory T cell development and function","volume":"8","author":"Seng","year":"2017","journal-title":"Journal of clinical & cellular immunology."},{"issue":"6","key":"10.1016\/j.intimp.2023.109797_b0085","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/08820139.2018.1480029","article-title":"Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed Rheumatoid Arthritis patients","volume":"47","author":"Zafari","year":"2018","journal-title":"Immunological investigations."},{"issue":"1","key":"10.1016\/j.intimp.2023.109797_b0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society."},{"issue":"6","key":"10.1016\/j.intimp.2023.109797_b0095","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/01.ftd.0000184162.60197.c1","article-title":"Pharmacokinetic behavior of rituximab: a study of different schedules of administration for heterogeneous clinical settings","volume":"27","author":"Regazzi","year":"2005","journal-title":"Therapeutic drug monitoring."},{"issue":"7","key":"10.1016\/j.intimp.2023.109797_b0100","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s43032-020-00431-z","article-title":"Decreased frequency of CD8+ HLA-G+ T cell in the peripheral blood of primary unexplained infertile females","volume":"28","author":"Ehsani","year":"2021","journal-title":"Reproductive Sciences."},{"key":"10.1016\/j.intimp.2023.109797_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2022.05.001","article-title":"Increased frequency of activated regulatory T cells in patients with lupus nephritis","author":"Pourreza","year":"2022","journal-title":"Human Immunology"},{"issue":"4","key":"10.1016\/j.intimp.2023.109797_b0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"methods."},{"issue":"7","key":"10.1016\/j.intimp.2023.109797_b0115","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"315","author":"Bluestone","year":"2015","journal-title":"Science translational medicine."},{"issue":"6","key":"10.1016\/j.intimp.2023.109797_b0120","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple sclerosis and regulatory T cells","volume":"28","author":"Costantino","year":"2008","journal-title":"Journal of clinical immunology."},{"issue":"8","key":"10.1016\/j.intimp.2023.109797_b0125","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/jnr.20852","article-title":"Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+ CD25+ regulatory T-cell function and FOXP3 expression","volume":"83","author":"Venken","year":"2006","journal-title":"Journal of neuroscience research."},{"issue":"5","key":"10.1016\/j.intimp.2023.109797_b0130","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4049\/jimmunol.1201379","article-title":"Helios+ and Helios\u2212 cells coexist within the natural FOXP3+ T regulatory cell subset in humans","volume":"190","author":"Himmel","year":"2013","journal-title":"The Journal of Immunology."},{"issue":"1","key":"10.1016\/j.intimp.2023.109797_b0135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4049\/jimmunol.1501704","article-title":"Helios controls a limited subset of regulatory T cell functions","volume":"196","author":"Sebastian","year":"2016","journal-title":"The Journal of Immunology."},{"key":"10.1016\/j.intimp.2023.109797_b0140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fimmu.2017.00619","article-title":"Intratumoral FoxP3+ Helios+ regulatory T cells upregulating immunosuppressive molecules are expanded in human colorectal cancer","volume":"8","author":"Syed Khaja","year":"2017","journal-title":"Frontiers in Immunology."},{"issue":"5","key":"10.1016\/j.intimp.2023.109797_b0145","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1038\/cti.2017.18","article-title":"Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis","volume":"6","author":"Jones","year":"2017","journal-title":"Clinical & translational immunology."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:22:03Z","timestamp":1719231723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"alternative-id":["S1567576923001200"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109797","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased frequency of regulatory T cells and level of helios gene expression in secondary progressive multiple sclerosis patients: Evidence about the development of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109797"}}